Form 4 for IBRX ImmunityBio, Inc.
Accepted 2023-01-04 00:00:00 ET · period of report 2022-12-31 · accession 0001326110-23-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-04 | 2022-12-31 | IBRX | Sachs David C. | CFO | M - OptEx | $0.00 | +7,598 | 51.3K | +17% | $0 |
| D | 2023-01-04 | 2022-12-31 | IBRX | Sachs David C. | CFO | M - OptEx | $0.00 | -7,598 | 136.8K | -5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-31 | M | A | 7,598 | $0.00 | 51,298 | D | — | — | |
| 2 | Derivative | Restricted Stock Units | 2022-12-31 | M | D | 7,598 | $0.00 | 136,793 | D | — · — to — | 7,598 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of ImmunityBio, Inc. common stock. (F2) 17,242 of the RSUs vested on December 9, 2021. Five percent (5%) of the remaining 151,989 RSUs (rounded down to the nearest whole share) vested on September 9, 2021; five percent (5%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2022; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) will vest on December 31, 2023; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) will vest on December 31, 2024; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) will vest on December 31, 2025; and the remaining RSUs will vest on December 31, 2026. |